Lactacystin, 200 UG
Induces neuritogenesis. Potent and selective irreversible proteasome inhibitor. Specifically inhibits 20S proteasome (MCP; multicatalytic complex). Blocks proteasome activity by targeting the catalytic β-subunit. Apoptosis inducer. Anticancer compound. Upregulates HSP70 and HSP22. Induces differentiation and inhibits cell cycle progression in several tumor cell lines. Inhibits NF-κB activation by inhibiting IκB degradation. Cathepsin A inhibitor. β-Secretase activity inhibitor. Anti-adipogenic. Autophagy inducer.
Application Notes
Ubiquitination-Proteasome, Apoptosis, Cancer, Cell Biology, Enzyme Inhibitor, Autophagy
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
SKU | 0219586382 |
Application Notes | Ubiquitination-Proteasome, Apoptosis, Cancer, Cell Biology, Enzyme Inhibitor, Autophagy |
Base Catalog Number | 19586382 |
CAS # | 133343-34-7 |
Molecular Formula | C15H24N2O7S |
Molecular Weight | 376.4 |
Pack Size | 200 UG |
Solubility | Soluble in water, methanol, ethanol, DMSO, pyridine, acetonitrile or dimethyl formamide. Insoluble in hexane, benzene, chloroform or ethyl acetate. |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |